<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Sci (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Med Sci (Basel)</journal-id><journal-id journal-id-type="publisher-id">medsci</journal-id><journal-title-group><journal-title>Medical Sciences</journal-title></journal-title-group><issn pub-type="epub">2076-3271</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40407541</article-id><article-id pub-id-type="pmc">PMC12101210</article-id>
<article-id pub-id-type="doi">10.3390/medsci13020046</article-id><article-id pub-id-type="publisher-id">medsci-13-00046</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Trends in Heart Transplantation and Outcome Analysis: Nationwide Study Using the National Inpatient Sample and Readmission Database</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Varughese</surname><given-names>Vivek Joseph</given-names></name><xref rid="af1-medsci-13-00046" ref-type="aff">1</xref><xref rid="c1-medsci-13-00046" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Bhaskaran</surname><given-names>Aditya Sunil</given-names></name><xref rid="af2-medsci-13-00046" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Tran</surname><given-names>Hadrian Hoang-Vu</given-names></name><xref rid="af3-medsci-13-00046" ref-type="aff">3</xref><xref rid="c1-medsci-13-00046" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Wadhwani</surname><given-names>Nikita</given-names></name><xref rid="af3-medsci-13-00046" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Nagesh</surname><given-names>Vignesh Krishnan</given-names></name><xref rid="af3-medsci-13-00046" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Aguilar</surname><given-names>Izage Kianifar</given-names></name><xref rid="af3-medsci-13-00046" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Islek</surname><given-names>Damien</given-names></name><xref rid="af3-medsci-13-00046" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Weissman</surname><given-names>Simcha</given-names></name><xref rid="af3-medsci-13-00046" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Atoot</surname><given-names>Adam</given-names></name><xref rid="af3-medsci-13-00046" ref-type="aff">3</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Torres</surname><given-names>Antoni</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-medsci-13-00046"><label>1</label>Department of Internal Medicine, University of South Carolina, Prisma Health, 2 Med Park, Richland, WA 29203, USA</aff><aff id="af2-medsci-13-00046"><label>2</label>Department of Internal Medicine, Lincoln Medical Center, New York, NY 10451, USA; <email>sunilbhaskaranaditya@gmail.com</email></aff><aff id="af3-medsci-13-00046"><label>3</label>Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA; <email>nikita.wadhwani@hmhn.org</email> (N.W.); <email>vgneshkrishnan@gmail.com</email> (V.K.N.); <email>izage.kianifaraguilar@hmhn.org</email> (I.K.A.); <email>damien.islek@hmhn.org</email> (D.I.); <email>simcha.weissman@hmhn.org</email> (S.W.); <email>adam.atoot@hmhn.org</email> (A.A.)</aff><author-notes><corresp id="c1-medsci-13-00046"><label>*</label>Correspondence: <email>vivekjvarughese@gmail.com</email> (V.J.V.); <email>hadrian.tran@hmhn.org</email> (H.H.-V.T.)</corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><volume>13</volume><issue>2</issue><elocation-id>46</elocation-id><history><date date-type="received"><day>13</day><month>3</month><year>2025</year></date><date date-type="rev-recd"><day>12</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>19</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Background: Heart transplantation (Htx) remains the definitive therapy for patients with end-stage heart failure. Despite advancements in mechanical circulatory support (MCS), immunosuppressive strategies, and organ allocation policies, donor availability remains a major limitation. This study analyzes the trends in Htx in the United States between 2016 and 2022, focusing on demographic shifts, mortality trends, and 30-day readmission patterns. Methods: We utilized the National Inpatient Sample (NIS) from 2016 to 2022 and the National Readmissions Database (NRD) for 2021 to identify Htx admissions using ICD-10 PCS code O2YA0Z0. Patient characteristics, mortality rates, and readmission patterns were analyzed using ANOVA and multivariate logistic regression, with statistical significance defined as <italic toggle="yes">p</italic> &#x0003c; 0.05. Results: The total number of Htx procedures increased from 641 in 2016 to 773 in 2022. The mean age of transplant recipients remained between 45 and 50 years, with no significant differences across years. Racial and socioeconomic disparities persisted, with approximately 60% of transplants occurring in White patients and 21&#x02013;26% of recipients belonging to the lowest income quartile. All-cause in-hospital mortality remained stable at 4&#x02013;7%. The 30-day readmission rate in 2021 was 57.7%, with heart failure, transplant rejection, and infections being the leading causes. Peripheral vascular disease (PVD) was the only comorbidity significantly associated with higher 30-day readmission risk (OR: 1.815, 95% CI: 1.477&#x02013;2.230). Conclusions: Htx utilization has increased over time, driven by improvements in donor allocation and perioperative management. However, racial and socioeconomic disparities remain, and readmission rates continue to be high. Future efforts should focus on optimizing post-transplant care and addressing disparities to improve long-term outcomes.</p></abstract><kwd-group><kwd>heart transplantation</kwd><kwd>heart failure</kwd><kwd>donor availability</kwd><kwd>mechanical circulatory support</kwd><kwd>left ventricular assist device</kwd><kwd>ECMO</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-medsci-13-00046"><title>1. Introduction</title><p>Heart transplantation (Htx) remains the last therapeutic resource for patients with end-stage advanced heart failure (HF). In 2018, UNOS changed the organ allocation policy for HTx. This was aimed at prioritizing patients with severe clinical conditions and, thereby, resulted in a reduction in mortality of people on the waiting list. Advanced heart failure and resistant angina are the current main indications for Htx, while active infections, peripheral vascular diseases, active malignancy, and morbid obesity are the contraindications [<xref rid="B1-medsci-13-00046" ref-type="bibr">1</xref>]. Recent advancements in the realm of immunosuppressive medications have also contributed to better outcomes in patients undergoing Htx. Although 2023 marked the year with the highest number of transplants performed in the United States (US), donor availability still remains the main challenge in the expansion of this therapeutic strategy. Recently, there have been significant advances in organ allocation, donor&#x02013;recipient matching, organ preservation, and expansion of the donor pool [<xref rid="B2-medsci-13-00046" ref-type="bibr">2</xref>]. Innovations in the field of mechanical circulatory support (MCS) systems, including left ventricular assist device (LVAD) technologies, have further increased the scope of Htx. Although initially used as a bridge to Htx, the use of LVAD technologies as a destination therapy has been widely utilized, especially since the advent of the HeartMate II systems [<xref rid="B3-medsci-13-00046" ref-type="bibr">3</xref>]. Advancement in the field of extracorporeal membrane oxygenation (ECMO) has also contributed to better patient outcomes by the advanced cardiopulmonary bypass these systems can provide in the recovery phase [<xref rid="B4-medsci-13-00046" ref-type="bibr">4</xref>]. Beyond allocating donors, other factors that play a critical role in Htx include ABO/HLA compatibility, appropriate matching of graft size, ischemic time involved, age, and comorbid infections present at the time of transplantation [<xref rid="B1-medsci-13-00046" ref-type="bibr">1</xref>]. The increased use of hearts from donors after circulatory death (DCD) has expanded the donor pool and has contributed to a rise in transplant numbers over the years [<xref rid="B5-medsci-13-00046" ref-type="bibr">5</xref>]. The use of hearts from donors with hepatitis C virus (HCV) infection has also become more common, facilitated by effective antiviral treatments that mitigate the risk of HCV transmission to recipients [<xref rid="B6-medsci-13-00046" ref-type="bibr">6</xref>].</p><p>In this study, we utilized the National Inpatient Sample (NIS) and National Readmissions Database (NRD) to analyze the trends in Htx in the US between 2016 and 2022. NIS and NRD are the largest publicly available identified patient databases available in the US.</p></sec><sec sec-type="methods" id="sec2-medsci-13-00046"><title>2. Methods</title><p>The NIS for the years 2016 to 2022 and NRD for the year 2021 were used for the analysis. All statistical analyses were performed using STATA 18.5 MP. ICD 10 PCS code O2YA0Z0 was used to select admissions for Htx in the NIS and the NRD. Population stratification was performed. One-way ANOVA was used to stratify the differences in patient characteristics over the years (Kolmogorov&#x02013;Smirnov test). A two-tailed <italic toggle="yes">p</italic> value &#x0003c; 0.05 was used to determine statistical significance of differences across the years. Index admissions requiring Htx were selected in the NRD, and 30-day readmission events were analyzed. Index admissions for Htx were stratified based on the readmissions in the 60 days following discharge. Patient factors including socioeconomic factors as well comorbidities were studied in both groups. Variance was analyzed using ANOVA. Factors that held significant association with the requirement of readmission in the 60 days following discharge in the ANOVA were used in multivariate logistic regression (probit model). Patient factors that held significant association with readmissions were analyzed, with statistical significance determined by a two-tailed <italic toggle="yes">p</italic> value &#x0003c; 0.05.</p></sec><sec sec-type="results" id="sec3-medsci-13-00046"><title>3. Results</title><p>Overall trends in Htx between the years 2016 and 2022 were analyzed using the NIS for the respective years. Population data are summarized in <xref rid="medsci-13-00046-t001" ref-type="table">Table 1</xref>.</p><p>A general upward trend was observed in the total number of heart transplantations (<xref rid="medsci-13-00046-f001" ref-type="fig">Figure 1</xref>). A total of 773 heart transplantations were documented in 2022 compared to 641 in 2016.</p><p>The mean age of admissions for Htx shows a consistent trend over the years (<xref rid="medsci-13-00046-f002" ref-type="fig">Figure 2</xref>). The mean age of Htx admissions has remained between 45 and 50 years, with 95% confidence. ANOVA across the years showed no difference in mean age for Htx admissions over the years.</p><p>Analyzing <xref rid="medsci-13-00046-f003" ref-type="fig">Figure 3</xref>, the admissions for Htx that belonged to the lowest quartile of monthly income remained consistent over the years. The percentage has remained between 21% and 26%, with 95% confidence. Racial stratification did not show any significant variance across the years.</p><p><xref rid="medsci-13-00046-f004" ref-type="fig">Figure 4</xref> depicts the trends in all-cause mortality associated with Htx admissions between 2016 and 2022. No difference in all-cause mortality was observed over the years in the ANOVA test (<italic toggle="yes">p</italic> value: 0.752).</p><p>Using the National Readmission Database 2021, we identified patients who underwent a heart transplant between the months of January and November of 2021 and analyzed the readmission events in the 30 days following discharge of the index admission event. We identified 2775 index admission events for heart transplantation. Of this patient population, 1601 readmission events were recorded in the 30 days following discharge of the initial admission. Major readmission causes are summarized in <xref rid="medsci-13-00046-f005" ref-type="fig">Figure 5</xref>.</p><p>Multivariate regression analysis was performed to analyze factors that held significant association with 30-day readmissions following Htx. Regression analysis was performed accounting for age, sex, race, mortality predictive indices during the admission, and comorbid conditions that held significant variance in the ANOVA. A two-tailed <italic toggle="yes">p</italic> value &#x0003c; 0.05 was used to determine statistical significance. A documented diagnosis of peripheral vascular disease (OR: 1.815 95% CI: 1.477&#x02013;2.230) was found to have a significant association with 30-day readmission following Htx. The results are summarized in <xref rid="medsci-13-00046-f006" ref-type="fig">Figure 6</xref>.</p></sec><sec sec-type="discussion" id="sec4-medsci-13-00046"><title>4. Discussion</title><p>With advancements in MCS and organ allocation strategies, the use of heart transplantation as a therapeutic strategy in the management of advanced heart failure has been showing an upward trend over the years (<xref rid="medsci-13-00046-t001" ref-type="table">Table 1</xref>, <xref rid="medsci-13-00046-f001" ref-type="fig">Figure 1</xref>). Since 2021, the number of patients awaiting heart transplant at the beginning and end of the year has declined, despite more additions to the list than ever; this is primarily due to transplants because removals for death or &#x0201c;Other&#x0201d; reasons have declined, while removals for improvement, being too ill, or patient declining have remained stable. In 2020, there was a decrease in new additions to the waiting list, most likely due to the pandemic; however, since then, the number of new additions has increased by 1064 (26.6%). Between 2013 and 2023, the number of candidates awaiting transplant on December 31 of a given year decreased 15.2% [<xref rid="B6-medsci-13-00046" ref-type="bibr">6</xref>]. With the evolving technologies at donor allocation and matching coupled with advancements in the realm of immunosuppressive medications improving outcomes, the trend is expected to increase over the coming years.</p><p>In our analysis, the mean age of patients undergoing Htx has remained consistently between 45 and 50 over the years (<xref rid="medsci-13-00046-f002" ref-type="fig">Figure 2</xref>). The American Society of Transplant Physicians and the National Institutes of Health have stated that age alone should not be considered a contraindication for heart transplantation, although patients over the age of 50 years may warrant additional screening for comorbid conditions [<xref rid="B7-medsci-13-00046" ref-type="bibr">7</xref>]. The American Heart Association has traditionally considered age 55 years as an upper limit but acknowledges that carefully selected patients older than 55 years can successfully undergo heart transplantation [<xref rid="B8-medsci-13-00046" ref-type="bibr">8</xref>]. Most centers do not select candidates above 65 years of age for Htx [<xref rid="B9-medsci-13-00046" ref-type="bibr">9</xref>]. In a retrospective analysis by Awad et al. [<xref rid="B10-medsci-13-00046" ref-type="bibr">10</xref>], similar 1-, 5-, and 10-year outcomes were observed in Htx recipients over 70 years of age when compared to younger recipients. Similar results were observed in two other retrospective studies [<xref rid="B11-medsci-13-00046" ref-type="bibr">11</xref>,<xref rid="B12-medsci-13-00046" ref-type="bibr">12</xref>]. While there is no absolute age cutoff, patients up to 70 years old are generally considered for heart transplantation, and those older than 70 years may be considered on a case-by-case basis, with careful selection criteria. There is a general paucity in the guidelines for definition of comorbidities that drive the decision for Htx in the elderly. With more data coming in suggestive of favorable outcomes in elderly patients, the mean age for heart transplantation candidates is expected to rise over the years. Of the total number of heart transplantations between 2016 and 2022, 23.12% of the transplants were for admissions with a documented diagnosis of congenital heart disease. The prevalence of pulmonary hypertension in the population that underwent transplantation was 9.23%. Despite the growing advancements in technologies as well as mechanical circulatory support systems, the all-cause in-hospital mortality has remained stable over the years. Major reasons postulated for this trend are the increasing number of transplant rejections in the population.</p><p>Racial disparities in heart transplantation are well documented and multifaceted, affecting both access to transplantation and post-transplant outcomes. Analyzing <xref rid="medsci-13-00046-f003" ref-type="fig">Figure 3</xref>, it is observed that around 60% of patients undergoing heart transplantation are white, and this trend has remained consistent over the years. Black and Hispanic patients are less likely to undergo heart transplantation compared to White patients. Despite an increase in the proportion of Black and Hispanic patients listed for transplantation, Black patients still have a lower likelihood of being transplanted, even with the new allocation system [<xref rid="B13-medsci-13-00046" ref-type="bibr">13</xref>,<xref rid="B14-medsci-13-00046" ref-type="bibr">14</xref>]. Additionally, Black patients are more likely to be listed with higher urgency statuses, yet they face higher waitlist mortality compared to White patients [<xref rid="B15-medsci-13-00046" ref-type="bibr">15</xref>]. Hispanic recipients are more likely to experience failure to rescue (FTR), defined as the inability to prevent mortality after postoperative complications, compared to White recipients. However, Black recipients do not show significant differences in FTR rates but have lower overall survival [<xref rid="B16-medsci-13-00046" ref-type="bibr">16</xref>]. The combination of donor and recipient race also impacts outcomes. Black recipients, regardless of donor race, have decreased survival compared to White recipients [<xref rid="B17-medsci-13-00046" ref-type="bibr">17</xref>]. The percentage of women who receive Htx has remained below 35% consistently between 2016 and 2022 (<xref rid="medsci-13-00046-f003" ref-type="fig">Figure 3</xref>). Women are less likely to be referred for advanced heart failure therapies, including heart transplantation, compared to men. This may be due to implicit biases, differences in disease presentation, and concerns about sensitization [<xref rid="B18-medsci-13-00046" ref-type="bibr">18</xref>,<xref rid="B19-medsci-13-00046" ref-type="bibr">19</xref>]. Women experience higher waitlist mortality, particularly at the highest urgency status. This is partly due to adverse events associated with temporary mechanical circulatory support devices [<xref rid="B20-medsci-13-00046" ref-type="bibr">20</xref>]. While post-transplant survival rates are generally similar between men and women, women are more likely to die from rejection and primary graft failure, whereas men are more likely to die from malignancies [<xref rid="B21-medsci-13-00046" ref-type="bibr">21</xref>,<xref rid="B22-medsci-13-00046" ref-type="bibr">22</xref>].</p><p>All-cause mortality for Htx had a consistent trend in our analysis (<xref rid="medsci-13-00046-f004" ref-type="fig">Figure 4</xref>), with the rates falling within 4&#x02013;7% across the years, with 95% confidence. Analyzing the literature, mortality trends associated with heart transplantation have been improving over the past few decades. Recent data from the OPTN/SRTR 2022 Annual Data Report, published by the American Society of Transplantation and the American Society of Transplant Surgeons, indicate that post-transplant mortality has been stable to slightly better since 2011. For adult recipients who underwent transplants between 2015 and 2017, the 1-, 3-, and 5-year survival rates were 91.3%, 85.7%, and 80.4%, respectively [<xref rid="B6-medsci-13-00046" ref-type="bibr">6</xref>]. A study published in The Annals of Thoracic Surgery in 2021 found that the 10-year survival rate for heart transplant recipients was 53%, with a standardized mortality rate (SMR) of 2.84 compared to the general population. This study also noted that long-term mortality rates have consistently declined over time [<xref rid="B23-medsci-13-00046" ref-type="bibr">23</xref>].</p><p>The 30-day readmission rate following Htx was 57.69% (1601 readmission events in 2775 index admissions). Heart failure (HF) was noted to be the major readmission cause in the 30 days following transplant, with 522 readmission events documented. Transplant rejection and infections were other major readmission causes in the 30-day period. In a retrospective analysis performed by Campos et al. [<xref rid="B24-medsci-13-00046" ref-type="bibr">24</xref>], the 90-day readmission rate following Htx was noted to be 49.4%, with infections and transplant rejection noted to be the major causes for readmission. In the multivariate regression analysis, peripheral vascular disease (PVD) was the only comorbidity found to have a significant association with 30-day readmission following Htx (OR: 1.815 95% CI: 1.477&#x02013;2.230). A study analyzing data from the United Network of Organ Sharing (UNOS) database found that patients with pre-transplant symptomatic PVD had significantly lower 1-, 5-, and 10-year survival rates compared to those without PVD (91.5% vs. 94.9%, 74.8% vs. 82.6%, and 48.6% vs. 54.7%, respectively) [<xref rid="B25-medsci-13-00046" ref-type="bibr">25</xref>]. Additionally, the presence of PVD can complicate the post-transplant period, as patients with PVD may require additional vascular interventions, such as revascularization or amputation, which can further impact their overall health and recovery [<xref rid="B26-medsci-13-00046" ref-type="bibr">26</xref>]. The American Heart Association (AHA) also notes that the wide spectrum of peripheral and cerebrovascular disease makes it challenging to establish specific exclusion criteria for HT. However, the potential for acute thrombotic or embolic events, the need for postoperative intra-aortic balloon support, and the effects of corticosteroids on atherosclerotic progression are important considerations [<xref rid="B8-medsci-13-00046" ref-type="bibr">8</xref>]. Although prior retrospective studies [<xref rid="B27-medsci-13-00046" ref-type="bibr">27</xref>] have proved uncontrolled hypertension as an independent risk factor for readmissions following Htx, no significant association was seen in our analysis.</p><p>The total artificial heart (TAH) has been postulated as the future of advanced heart failure management and would be a potential solution for candidates not eligible for heart transplantation. Although being designed as a bridge to transplant, its use as a destination therapy, just like LVADs, is increasingly being considered [<xref rid="B28-medsci-13-00046" ref-type="bibr">28</xref>]. The SynCardia TAH, the only FDA-approved TAH, is a pulsatile system capable of providing flows greater than 9 L/min. It is indicated for patients at imminent risk of death from non-reversible biventricular failure. The American Heart Association notes that the TAH is reserved for patients with severe biventricular failure who are not candidates for other mechanical circulatory support devices, like left ventricular assist devices (LVADs) [<xref rid="B29-medsci-13-00046" ref-type="bibr">29</xref>].</p></sec><sec sec-type="conclusions" id="sec5-medsci-13-00046"><title>5. Conclusions</title><p>There has been a general increasing trend in the total number of heart transplantations between 2016 and 2022. All-cause mortality associated with Htx has remained stable at 4&#x02013;7% across the years. The percentage of females undergoing Htx has remained consistently below 35% between 2016 and 2022. Heart failure and related conditions, transplant rejection, and infections were the major admission causes in the 30 days following Htx. Peripheral vascular disease (PVD) held significant association with 30-day readmission following Htx.</p></sec><sec id="sec6-medsci-13-00046"><title>6. Limitations of This Study</title><p>While the NIS and the NRD have utility in large population studies, these databases are not without limitations: one potential limitation is the reasons for the in-hospital mortality were not documented for heart transplant admissions, making it a limitation. The ICD and PCS codes used for patient selection and stratification are subject to inter-operator variability.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>V.J.V. contributed to conceptualization, writing, and methodology; A.S.B., H.H.-V.T., N.W., I.K.A. and D.I. contributed to writing; V.K.N. was involved in reviewing; and S.W. and A.A. provided supervision. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>IRB statement is waived as the data was obtained from a publicly available database with de&#x02013;identified patient information.</p></notes><notes><title>Informed Consent Statement</title><p>Patient consent is waived as the data was obtained from a publicly available database with de&#x02013;identified patient information.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Analysis was performed using HCUP NRD/NIS: deidentified patient data from public database: no IRB approval or consents required.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-medsci-13-00046"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chrysakis</surname><given-names>N.</given-names></name>
<name><surname>Magouliotis</surname><given-names>D.E.</given-names></name>
<name><surname>Spiliopoulos</surname><given-names>K.</given-names></name>
<name><surname>Athanasiou</surname><given-names>T.</given-names></name>
<name><surname>Briasoulis</surname><given-names>A.</given-names></name>
<name><surname>Triposkiadis</surname><given-names>F.</given-names></name>
<name><surname>Skoularigis</surname><given-names>J.</given-names></name>
<name><surname>Xanthopoulos</surname><given-names>A.</given-names></name>
</person-group><article-title>Heart Transplantation</article-title><source>J. Clin. Med.</source><year>2024</year><volume>13</volume><elocation-id>558</elocation-id><!--<pub-id pub-id-type="pmcid">PMC10816008</pub-id>--><pub-id pub-id-type="doi">10.3390/jcm13020558</pub-id><pub-id pub-id-type="pmid">38256691</pub-id>
</element-citation></ref><ref id="B2-medsci-13-00046"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Coniglio</surname><given-names>A.C.</given-names></name>
<name><surname>Patel</surname><given-names>C.B.</given-names></name>
<name><surname>Kittleson</surname><given-names>M.</given-names></name>
<name><surname>Schlendorf</surname><given-names>K.</given-names></name>
<name><surname>Schroder</surname><given-names>J.N.</given-names></name>
<name><surname>DeVore</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Innovations in Heart Transplantation: A Review</article-title><source>J. Card. Fail.</source><year>2022</year><volume>28</volume><fpage>467</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1016/j.cardfail.2021.10.011</pub-id><pub-id pub-id-type="pmid">34752907</pub-id>
</element-citation></ref><ref id="B3-medsci-13-00046"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miller</surname><given-names>L.W.</given-names></name>
<name><surname>Guglin</surname><given-names>M.</given-names></name>
</person-group><article-title>Patient selection for ventricular assist devices: A moving target</article-title><source>J. Am. Coll. Cardiol.</source><year>2013</year><volume>61</volume><fpage>1209</fpage><lpage>1221</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2012.08.1029</pub-id><pub-id pub-id-type="pmid">23290542</pub-id>
</element-citation></ref><ref id="B4-medsci-13-00046"><label>4.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Tully</surname><given-names>A.</given-names></name>
<name><surname>Sharma</surname><given-names>S.</given-names></name>
<name><surname>Nagalli</surname><given-names>S.</given-names></name>
</person-group><article-title>Heart-Lung Transplantation</article-title><source>StatPearls</source><publisher-name>StatPearls Publishing</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2025</year></element-citation></ref><ref id="B5-medsci-13-00046"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>DeFilippis</surname><given-names>E.M.</given-names></name>
<name><surname>Khush</surname><given-names>K.K.</given-names></name>
<name><surname>Farr</surname><given-names>M.A.</given-names></name>
<name><surname>Fiedler</surname><given-names>A.</given-names></name>
<name><surname>Kilic</surname><given-names>A.</given-names></name>
<name><surname>Givertz</surname><given-names>M.M.</given-names></name>
</person-group><article-title>Evolving Characteristics of Heart Transplantation Donors and Recipients: JACC Focus Seminar</article-title><source>J. Am. Coll. Cardiol.</source><year>2022</year><volume>79</volume><fpage>1108</fpage><lpage>1123</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2021.11.064</pub-id><pub-id pub-id-type="pmid">35300823</pub-id>
</element-citation></ref><ref id="B6-medsci-13-00046"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Colvin</surname><given-names>M.M.</given-names></name>
<name><surname>Smith</surname><given-names>J.M.</given-names></name>
<name><surname>Ahn</surname><given-names>Y.S.</given-names></name>
<name><surname>Lindblad</surname><given-names>K.A.</given-names></name>
<name><surname>Handarova</surname><given-names>D.</given-names></name>
<name><surname>Israni</surname><given-names>A.K.</given-names></name>
<name><surname>Snyder</surname><given-names>J.J.</given-names></name>
</person-group><article-title>OPTN/SRTR 2023 Annual Data Report: Heart</article-title><source>Am. J. Transplant.</source><year>2025</year><volume>25</volume><fpage>S329</fpage><lpage>S421</lpage><pub-id pub-id-type="doi">10.1016/j.ajt.2025.01.024</pub-id><pub-id pub-id-type="pmid">39947807</pub-id>
</element-citation></ref><ref id="B7-medsci-13-00046"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miller</surname><given-names>L.W.</given-names></name>
</person-group><article-title>Listing criteria for cardiac transplantation: Results of an American Society of Transplant Physicians-National Institutes of Health conference</article-title><source>Transplantation</source><year>1998</year><volume>66</volume><fpage>947</fpage><lpage>951</lpage><pub-id pub-id-type="doi">10.1097/00007890-199810150-00032</pub-id><pub-id pub-id-type="pmid">9798715</pub-id>
</element-citation></ref><ref id="B8-medsci-13-00046"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Costanzo</surname><given-names>M.R.</given-names></name>
<name><surname>Augustine</surname><given-names>S.</given-names></name>
<name><surname>Bourge</surname><given-names>R.</given-names></name>
<name><surname>Bristow</surname><given-names>M.</given-names></name>
<name><surname>O&#x02019;connell</surname><given-names>J.B.</given-names></name>
<name><surname>Driscoll</surname><given-names>D.</given-names></name>
<name><surname>Rose</surname><given-names>E.</given-names></name>
</person-group><article-title>Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association</article-title><source>Circulation</source><year>1995</year><volume>92</volume><fpage>3593</fpage><lpage>3612</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.92.12.3593</pub-id><pub-id pub-id-type="pmid">8521589</pub-id>
</element-citation></ref><ref id="B9-medsci-13-00046"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Steinman</surname><given-names>T.I.</given-names></name>
<name><surname>Becker</surname><given-names>B.N.</given-names></name>
<name><surname>Frost</surname><given-names>A.E.</given-names></name>
<name><surname>Olthoff</surname><given-names>K.M.</given-names></name>
<name><surname>Smart</surname><given-names>F.W.</given-names></name>
<name><surname>Suki</surname><given-names>W.N.</given-names></name>
<name><surname>Wilkinson</surname><given-names>A.H.</given-names></name>
<collab>Clinical Practice Committee, American Society of Transplantation</collab>
</person-group><article-title>Guidelines for the referral and management of patients eligible for solid organ transplantation</article-title><source>Transplantation</source><year>2001</year><volume>71</volume><fpage>1189</fpage><lpage>1204</lpage><pub-id pub-id-type="doi">10.1097/00007890-200105150-00001</pub-id><pub-id pub-id-type="pmid">11397947</pub-id>
</element-citation></ref><ref id="B10-medsci-13-00046"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Awad</surname><given-names>M.</given-names></name>
<name><surname>Czer</surname><given-names>L.</given-names></name>
<name><surname>Mirocha</surname><given-names>J.</given-names></name>
<name><surname>Ruzza</surname><given-names>A.</given-names></name>
<name><surname>de Robertis</surname><given-names>M.</given-names></name>
<name><surname>Rafiei</surname><given-names>M.</given-names></name>
<name><surname>Reich</surname><given-names>H.</given-names></name>
<name><surname>Sasevich</surname><given-names>M.</given-names></name>
<name><surname>Rihbany</surname><given-names>K.</given-names></name>
<name><surname>Kass</surname><given-names>R.</given-names></name>
<etal/>
</person-group><article-title>Similar Mortality and Morbidity of Orthotopic Heart Transplantation for Patients 70 Years of Age and Older Compared with Younger Patients</article-title><source>Transplant. Proc.</source><year>2016</year><volume>48</volume><fpage>2782</fpage><lpage>2791</lpage><pub-id pub-id-type="doi">10.1016/j.transproceed.2016.06.039</pub-id><pub-id pub-id-type="pmid">27788818</pub-id>
</element-citation></ref><ref id="B11-medsci-13-00046"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jaiswal</surname><given-names>A.</given-names></name>
<name><surname>Gadela</surname><given-names>N.V.</given-names></name>
<name><surname>Baran</surname><given-names>D.</given-names></name>
<name><surname>Balakumaran</surname><given-names>K.</given-names></name>
<name><surname>Scatola</surname><given-names>A.</given-names></name>
<name><surname>Radojevic</surname><given-names>J.</given-names></name>
<name><surname>Gluck</surname><given-names>J.</given-names></name>
<name><surname>Arora</surname><given-names>S.</given-names></name>
<name><surname>Hammond</surname><given-names>J.</given-names></name>
<name><surname>Ali</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Clinical outcomes of older adults listed for heart transplantation in the United States</article-title><source>J. Am. Geriatr. Soc.</source><year>2021</year><volume>69</volume><fpage>2507</fpage><lpage>2517</lpage><pub-id pub-id-type="doi">10.1111/jgs.17271</pub-id><pub-id pub-id-type="pmid">34105139</pub-id>
</element-citation></ref><ref id="B12-medsci-13-00046"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cooper</surname><given-names>L.B.</given-names></name>
<name><surname>Lu</surname><given-names>D.</given-names></name>
<name><surname>Mentz</surname><given-names>R.J.</given-names></name>
<name><surname>Rogers</surname><given-names>J.G.</given-names></name>
<name><surname>Milano</surname><given-names>C.A.</given-names></name>
<name><surname>Felker</surname><given-names>G.M.</given-names></name>
<name><surname>Hernandez</surname><given-names>A.F.</given-names></name>
<name><surname>Patel</surname><given-names>C.B.</given-names></name>
</person-group><article-title>Cardiac transplantation for older patients: Characteristics and outcomes in the septuagenarian population</article-title><source>J. Heart Lung Transplant.</source><year>2016</year><volume>35</volume><fpage>362</fpage><lpage>369</lpage><!--<pub-id pub-id-type="pmcid">PMC4789155</pub-id>--><pub-id pub-id-type="doi">10.1016/j.healun.2015.10.028</pub-id><pub-id pub-id-type="pmid">26632028</pub-id>
</element-citation></ref><ref id="B13-medsci-13-00046"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chouairi</surname><given-names>F.</given-names></name>
<name><surname>Fuery</surname><given-names>M.</given-names></name>
<name><surname>Clark</surname><given-names>K.A.</given-names></name>
<name><surname>Mullan</surname><given-names>C.W.</given-names></name>
<name><surname>Stewart</surname><given-names>J.</given-names></name>
<name><surname>Caraballo</surname><given-names>C.</given-names></name>
<name><surname>Clarke</surname><given-names>J.D.</given-names></name>
<name><surname>Sen</surname><given-names>S.</given-names></name>
<name><surname>Guha</surname><given-names>A.</given-names></name>
<name><surname>Ibrahim</surname><given-names>N.E.</given-names></name>
<etal/>
</person-group><article-title>Evaluation of Racial and Ethnic Disparities in Cardiac Transplantation</article-title><source>J. Am. Heart Assoc.</source><year>2021</year><volume>10</volume><fpage>e021067</fpage><!--<pub-id pub-id-type="pmcid">PMC8649228</pub-id>--><pub-id pub-id-type="doi">10.1161/JAHA.120.021067</pub-id><pub-id pub-id-type="pmid">34431324</pub-id>
</element-citation></ref><ref id="B14-medsci-13-00046"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Firoz</surname><given-names>A.</given-names></name>
<name><surname>Remer</surname><given-names>D.</given-names></name>
<name><surname>Zhao</surname><given-names>H.</given-names></name>
<name><surname>Lu</surname><given-names>X.</given-names></name>
<name><surname>Hamad</surname><given-names>E.</given-names></name>
</person-group><article-title>Racial and ethnic disparities on the heart transplant waiting list</article-title><source>Int. J. Cardiol.</source><year>2025</year><volume>423</volume><fpage>132971</fpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2025.132971</pub-id><pub-id pub-id-type="pmid">39814184</pub-id>
</element-citation></ref><ref id="B15-medsci-13-00046"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Singh</surname><given-names>T.P.</given-names></name>
<name><surname>Almond</surname><given-names>C.S.</given-names></name>
<name><surname>Taylor</surname><given-names>D.O.</given-names></name>
<name><surname>Milliren</surname><given-names>C.E.</given-names></name>
<name><surname>Graham</surname><given-names>D.A.</given-names></name>
</person-group><article-title>Racial and ethnic differences in wait-list outcomes in patients listed for heart transplantation in the United States</article-title><source>Circulation</source><year>2012</year><volume>125</volume><fpage>3022</fpage><lpage>3030</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.092643</pub-id><pub-id pub-id-type="pmid">22589383</pub-id>
</element-citation></ref><ref id="B16-medsci-13-00046"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abrahim</surname><given-names>O.</given-names></name>
<name><surname>Premkumar</surname><given-names>A.B.</given-names></name>
<name><surname>Kubi</surname><given-names>B.</given-names></name>
<name><surname>Wolfe</surname><given-names>S.B.</given-names></name>
<name><surname>Paneitz</surname><given-names>D.C.</given-names></name>
<name><surname>Singh</surname><given-names>R.</given-names></name>
<name><surname>Thomas</surname><given-names>J.B.</given-names></name>
<name><surname>Michel</surname><given-names>E.</given-names></name>
<name><surname>Osho</surname><given-names>A.A.</given-names></name>
</person-group><article-title>Does Failure to Rescue Drive Race/Ethnicity-based Disparities in Survival After Heart Transplantation?</article-title><source>Ann. Surg.</source><year>2024</year><volume>279</volume><fpage>361</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1097/SLA.0000000000005890</pub-id><pub-id pub-id-type="pmid">37144385</pub-id>
</element-citation></ref><ref id="B17-medsci-13-00046"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Blitzer</surname><given-names>D.</given-names></name>
<name><surname>Pegues</surname><given-names>J.N.</given-names></name>
<name><surname>Lirette</surname><given-names>S.T.</given-names></name>
<name><surname>Baran</surname><given-names>D.A.</given-names></name>
<name><surname>Colvin</surname><given-names>M.</given-names></name>
<name><surname>Hayanga</surname><given-names>A.</given-names></name>
<name><surname>Copeland</surname><given-names>H.</given-names></name>
</person-group><article-title>Do outcomes for heart transplantation differ based on donor and recipient race?</article-title><source>Clin. Transplant.</source><year>2023</year><volume>37</volume><fpage>e15137</fpage><pub-id pub-id-type="doi">10.1111/ctr.15137</pub-id><pub-id pub-id-type="pmid">37725074</pub-id>
</element-citation></ref><ref id="B18-medsci-13-00046"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chung</surname><given-names>A.</given-names></name>
<name><surname>Hartman</surname><given-names>H.</given-names></name>
<name><surname>DeFilippis</surname><given-names>E.M.</given-names></name>
</person-group><article-title>Sex Differences in Cardiac Transplantation</article-title><source>Curr. Atheroscler. Rep.</source><year>2023</year><volume>25</volume><fpage>995</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1007/s11883-023-01169-0</pub-id><pub-id pub-id-type="pmid">38060058</pub-id>
</element-citation></ref><ref id="B19-medsci-13-00046"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Defilippis</surname><given-names>E.M.</given-names></name>
<name><surname>Truby</surname><given-names>L.K.</given-names></name>
<name><surname>Clerkin</surname><given-names>K.J.</given-names></name>
<name><surname>Donald</surname><given-names>E.</given-names></name>
<name><surname>Sinnenberg</surname><given-names>L.</given-names></name>
<name><surname>Varshney</surname><given-names>A.S.</given-names></name>
<name><surname>Cogswell</surname><given-names>R.</given-names></name>
<name><surname>Kittleson</surname><given-names>M.M.</given-names></name>
<name><surname>Haythe</surname><given-names>J.H.</given-names></name>
<name><surname>Givertz</surname><given-names>M.M.</given-names></name>
<etal/>
</person-group><article-title>Increased Opportunities for Transplantation for Women in the New Heart Allocation System</article-title><source>J. Card. Fail.</source><year>2022</year><volume>28</volume><fpage>1149</fpage><lpage>1157</lpage><!--<pub-id pub-id-type="pmcid">PMC10257979</pub-id>--><pub-id pub-id-type="doi">10.1016/j.cardfail.2022.03.354</pub-id><pub-id pub-id-type="pmid">35470056</pub-id>
</element-citation></ref><ref id="B20-medsci-13-00046"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>DeFilippis</surname><given-names>E.M.</given-names></name>
<name><surname>Masotti</surname><given-names>M.</given-names></name>
<name><surname>Blumer</surname><given-names>V.</given-names></name>
<name><surname>Maharaj</surname><given-names>V.</given-names></name>
<name><surname>Cogswell</surname><given-names>R.</given-names></name>
</person-group><article-title>Sex-Specific Outcomes of Candidates Listed as the Highest Priority Status for Heart Transplantation</article-title><source>Circ. Heart Fail.</source><year>2023</year><volume>16</volume><fpage>e009946</fpage><pub-id pub-id-type="doi">10.1161/CIRCHEARTFAILURE.122.009946</pub-id><pub-id pub-id-type="pmid">37232180</pub-id>
</element-citation></ref><ref id="B21-medsci-13-00046"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garc&#x000ed;a-Cos&#x000ed;o</surname><given-names>M.D.</given-names></name>
<name><surname>Gonz&#x000e1;lez-Vilchez</surname><given-names>F.</given-names></name>
<name><surname>L&#x000f3;pez-Vilella</surname><given-names>R.</given-names></name>
<name><surname>Barge-Caballero</surname><given-names>E.</given-names></name>
<name><surname>G&#x000f3;mez-Bueno</surname><given-names>M.</given-names></name>
<name><surname>Mart&#x000ed;nez-Selles</surname><given-names>M.</given-names></name>
<name><surname>Ariz&#x000f3;n</surname><given-names>J.M.</given-names></name>
<name><surname>Sousa</surname><given-names>D.R.</given-names></name>
<name><surname>Gonz&#x000e1;lez-Costello</surname><given-names>J.</given-names></name>
<name><surname>Mirabet</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Gender differences in heart transplantation: Twenty-five year trends in the nationwide Spanish heart transplant registry</article-title><source>Clin. Transplant.</source><year>2020</year><volume>34</volume><fpage>e14096</fpage><pub-id pub-id-type="doi">10.1111/ctr.14096</pub-id><pub-id pub-id-type="pmid">32978995</pub-id>
</element-citation></ref><ref id="B22-medsci-13-00046"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moayedi</surname><given-names>Y.</given-names></name>
<name><surname>Fan</surname><given-names>C.P.S.</given-names></name>
<name><surname>Cherikh</surname><given-names>W.S.</given-names></name>
<name><surname>Stehlik</surname><given-names>J.</given-names></name>
<name><surname>Teuteberg</surname><given-names>J.J.</given-names></name>
<name><surname>Ross</surname><given-names>H.J.</given-names></name>
<name><surname>Khush</surname><given-names>K.K.</given-names></name>
</person-group><article-title>Survival Outcomes After Heart Transplantation: Does Recipient Sex Matter?</article-title><source>Circ. Heart Fail.</source><year>2019</year><volume>12</volume><fpage>e006218</fpage><pub-id pub-id-type="doi">10.1161/CIRCHEARTFAILURE.119.006218</pub-id><pub-id pub-id-type="pmid">31597452</pub-id>
</element-citation></ref><ref id="B23-medsci-13-00046"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Suarez-Pierre</surname><given-names>A.</given-names></name>
<name><surname>Lui</surname><given-names>C.</given-names></name>
<name><surname>Zhou</surname><given-names>X.</given-names></name>
<name><surname>Giuliano</surname><given-names>K.</given-names></name>
<name><surname>Etchill</surname><given-names>E.</given-names></name>
<name><surname>Almaraz-Espinoza</surname><given-names>A.</given-names></name>
<name><surname>Crawford</surname><given-names>T.C.</given-names></name>
<name><surname>Fraser</surname><given-names>C.D.</given-names></name>
<name><surname>Whitman</surname><given-names>G.J.</given-names></name>
<name><surname>Choi</surname><given-names>C.W.</given-names></name>
<etal/>
</person-group><article-title>Long-term Survival After Heart Transplantation: A Population-based Nested Case-Control Study</article-title><source>Ann. Thorac. Surg.</source><year>2021</year><volume>111</volume><fpage>889</fpage><lpage>898</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2020.05.163</pub-id><pub-id pub-id-type="pmid">32739258</pub-id>
</element-citation></ref><ref id="B24-medsci-13-00046"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Campos</surname><given-names>I.W.</given-names></name>
<name><surname>Guimar&#x000e3;es</surname><given-names>P.O.</given-names></name>
<name><surname>Tavares</surname><given-names>C.A.</given-names></name>
<name><surname>Duque</surname><given-names>A.M.</given-names></name>
<name><surname>Marchi</surname><given-names>D.C.</given-names></name>
<name><surname>Marcondes-Braga</surname><given-names>F.G.</given-names></name>
<name><surname>Fernandes</surname><given-names>L.M.</given-names></name>
<name><surname>Aulicino</surname><given-names>G.B.</given-names></name>
<name><surname>Seguro</surname><given-names>L.F.</given-names></name>
<name><surname>Mangini</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Patterns and Risk Factors for Rehospitalizations Within the First 90 Days Following Discharge After Heart Transplantation</article-title><source>Transplant. Proc.</source><year>2024</year><volume>56</volume><fpage>1790</fpage><lpage>1797</lpage><pub-id pub-id-type="doi">10.1016/j.transproceed.2024.08.001</pub-id><pub-id pub-id-type="pmid">39209671</pub-id>
</element-citation></ref><ref id="B25-medsci-13-00046"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Enciso</surname><given-names>J.S.</given-names></name>
<name><surname>Kato</surname><given-names>T.S.</given-names></name>
<name><surname>Jin</surname><given-names>Z.</given-names></name>
<name><surname>Chung</surname><given-names>C.</given-names></name>
<name><surname>Yang</surname><given-names>J.</given-names></name>
<name><surname>Takayama</surname><given-names>H.</given-names></name>
<name><surname>Mancini</surname><given-names>D.M.</given-names></name>
<name><surname>Schulze</surname><given-names>P.C.</given-names></name>
</person-group><article-title>Effect of peripheral vascular disease on mortality in cardiac transplant recipients (from the United Network of Organ Sharing Database)</article-title><source>Am. J. Cardiol.</source><year>2014</year><volume>114</volume><fpage>1111</fpage><lpage>1115</lpage><!--<pub-id pub-id-type="pmcid">PMC4947142</pub-id>--><pub-id pub-id-type="doi">10.1016/j.amjcard.2014.07.027</pub-id><pub-id pub-id-type="pmid">25159237</pub-id>
</element-citation></ref><ref id="B26-medsci-13-00046"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bos</surname><given-names>L.</given-names></name>
<name><surname>Mirabet</surname><given-names>S.</given-names></name>
<name><surname>Brossa</surname><given-names>V.</given-names></name>
<name><surname>Lopez</surname><given-names>L.</given-names></name>
<name><surname>Sionis</surname><given-names>A.</given-names></name>
<name><surname>Capellades</surname><given-names>H.</given-names></name>
<name><surname>Cinca</surname><given-names>J.</given-names></name>
<name><surname>Roig</surname><given-names>E.</given-names></name>
</person-group><article-title>Role of Vascular Disease in the Evolution of Heart Transplant Patients</article-title><source>Transplant. Proc.</source><year>2015</year><volume>47</volume><fpage>2393</fpage><lpage>2394</lpage><pub-id pub-id-type="doi">10.1016/j.transproceed.2015.09.008</pub-id><pub-id pub-id-type="pmid">26518937</pub-id>
</element-citation></ref><ref id="B27-medsci-13-00046"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>M.</given-names></name>
<name><surname>Kim</surname><given-names>K.</given-names></name>
</person-group><article-title>Unplanned readmission of patients with heart transplantation in 1 year: A retrospective study</article-title><source>J. Adv. Nurs.</source><year>2020</year><volume>76</volume><fpage>824</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1111/jan.14280</pub-id><pub-id pub-id-type="pmid">31788841</pub-id>
</element-citation></ref><ref id="B28-medsci-13-00046"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cook</surname><given-names>J.A.</given-names></name>
<name><surname>Shah</surname><given-names>K.B.</given-names></name>
<name><surname>Quader</surname><given-names>M.A.</given-names></name>
<name><surname>Cooke</surname><given-names>R.H.</given-names></name>
<name><surname>Kasirajan</surname><given-names>V.</given-names></name>
<name><surname>Rao</surname><given-names>K.K.</given-names></name>
<name><surname>Smallfield</surname><given-names>M.C.</given-names></name>
<name><surname>Tchoukina</surname><given-names>I.</given-names></name>
<name><surname>Tang</surname><given-names>D.G.</given-names></name>
</person-group><article-title>The total artificial heart</article-title><source>J. Thorac. Dis.</source><year>2015</year><volume>7</volume><fpage>2172</fpage><lpage>2180</lpage><comment>Erratum in <italic toggle="yes">J. Thorac. Dis.</italic>
<bold>2017</bold>, <italic toggle="yes">9</italic>, E342. <uri xlink:href="https://doi.org/10.21037/jtd.2017.02.66">https://doi.org/10.21037/jtd.2017.02.66</uri></comment><!--<pub-id pub-id-type="pmcid">PMC4703693</pub-id>--><pub-id pub-id-type="doi">10.3978/j.issn.2072-1439.2015.10.70</pub-id><pub-id pub-id-type="pmid">26793338</pub-id>
</element-citation></ref><ref id="B29-medsci-13-00046"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Slepian</surname><given-names>M.J.</given-names></name>
<name><surname>Alemu</surname><given-names>Y.</given-names></name>
<name><surname>Soares</surname><given-names>J.S.</given-names></name>
<name><surname>Smith</surname><given-names>R.G.</given-names></name>
<name><surname>Einav</surname><given-names>S.</given-names></name>
<name><surname>Bluestein</surname><given-names>D.</given-names></name>
</person-group><article-title>The Syncardia&#x02122; total artificial heart: In vivo, in vitro, and computational modeling studies</article-title><source>J. Biomech.</source><year>2013</year><volume>46</volume><fpage>266</fpage><lpage>275</lpage><comment>Erratum in <italic toggle="yes">J. Biomech.</italic>
<bold>2013</bold>, <italic toggle="yes">46</italic>, 1414</comment><!--<pub-id pub-id-type="pmcid">PMC4162530</pub-id>--><pub-id pub-id-type="doi">10.1016/j.jbiomech.2012.11.032</pub-id><pub-id pub-id-type="pmid">23305813</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="medsci-13-00046-f001"><label>Figure 1</label><caption><p>Trends in total number of heart transplantations (2016&#x02013;2022).</p></caption><graphic xlink:href="medsci-13-00046-g001" position="float"/></fig><fig position="float" id="medsci-13-00046-f002"><label>Figure 2</label><caption><p>Trends in mean age of admissions undergoing heart transplantation.</p></caption><graphic xlink:href="medsci-13-00046-g002" position="float"/></fig><fig position="float" id="medsci-13-00046-f003"><label>Figure 3</label><caption><p>Stratification by race and income quartile for heart transplantation admissions (2016&#x02013;2022).</p></caption><graphic xlink:href="medsci-13-00046-g003" position="float"/></fig><fig position="float" id="medsci-13-00046-f004"><label>Figure 4</label><caption><p>Trends in all-cause mortality for heart transplantation admissions (2016&#x02013;2022).</p></caption><graphic xlink:href="medsci-13-00046-g004" position="float"/></fig><fig position="float" id="medsci-13-00046-f005"><label>Figure 5</label><caption><p>Major readmission causes in the 30 days following heart transplantation.</p></caption><graphic xlink:href="medsci-13-00046-g005" position="float"/></fig><fig position="float" id="medsci-13-00046-f006"><label>Figure 6</label><caption><p>Association of patient factors with 30-day readmission following heart transplantation.</p></caption><graphic xlink:href="medsci-13-00046-g006" position="float"/></fig><table-wrap position="float" id="medsci-13-00046-t001"><object-id pub-id-type="pii">medsci-13-00046-t001_Table 1</object-id><label>Table 1</label><caption><p>Population trends in heart transplantations (2016&#x02013;2022).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Year</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total Heart Transplants</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mean Age (95% CI)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Male (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Female (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Lowest Income Quartile Admissions (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">White (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Black (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hispanic (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">All-Cause In-Hospital Mortality (%)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">641</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.88 (45.30&#x02013;48.46)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">73.32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.68</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.03</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">59.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20.87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.52</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.14 (3.86&#x02013;7.15)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">595</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.82 (46.25&#x02013;49.40)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72.61</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.39</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60.07</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.58</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.51</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.04 (3.54&#x02013;7.12)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">704</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.72 (46.21&#x02013;49.23)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67.67</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.49</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">59.06</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.73</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.99</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.39 (4.80&#x02013;8.45)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2019</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">688</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.30 (45.85&#x02013;48.75)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">73.32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.68</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.88</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60.07</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.58</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.51</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.23 (3.79&#x02013;7.15)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">708</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.12 (47.71&#x02013;50.53)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">73.87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.85</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58.64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.56</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.23 (2.97&#x02013;5.99)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2021</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">723</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.81 (45.31&#x02013;48.31)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">73.87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.68</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.06</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.43</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.42 (3.14&#x02013;6.19)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2022</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">773</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.31 (46.95&#x02013;49.67)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">73.32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">59.06</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.73</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.99</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.04 (3.70&#x02013;6.83)</td></tr></tbody></table></table-wrap></floats-group></article>